(MENAFN- PR Newswire)
NEW YORK, Aug. 5, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
- Atlas Air Worldwide Holdings, Inc. (NASDAQ: AAWW )'s sale to funds managed by affiliates of Apollo Global Management, Inc. and affiliates of J.F. Lehman & Company and Hill City Capital for $102.50 per share in cash. If you are an Atlas shareholder, click here to learn more about your rights and options .
- ChemoCentryx, Inc. (NASDAQ: CCXI )'s sale to Amgen Inc. for $52.00 per share in cash. If you are a ChemoCentryx shareholder, click here to learn more about your rights and options .
- iRobot Corporation (NASDAQ: IRBT )'s sale to Amazon.com, Inc. for $61.00 per share in cash. If you are an iRobot shareholder, click here to learn more about your rights and options .
- RADA Electronic Industries Ltd. (NASDAQ: RADA )'s merger with Leonardo DRS Inc. If you are a RADA shareholder, click here to learn more about your rights and options .
Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:Halper Sadeh LLPDaniel Sadeh, Esq.Zachary Halper, Esq.(212) 763-0060[email protected] [email protected]
SOURCE Halper Sadeh LLP
MENAFN05082022003732001241ID1104653208
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.